Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page’s software/UI revision label is updated from `v3.5.2` to `v3.5.3`, indicating a minor technical release of the ClinicalTrials.gov interface rather than a modification to the underlying study record.
    Difference
    0.0%
    Check dated 2026-04-24T05:58:58.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.0%
    Check dated 2026-04-17T02:44:07.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:25:27.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added to the page. Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:20:40.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page history. This appears to be a minor site version update with no substantive changes to study data or navigation.
    Difference
    0.0%
    Check dated 2026-02-11T11:52:00.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the history and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-04T10:27:17.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.